Malignant Phyllodes Tumour of the Breast with Liposarcomatous Differentiation: A Rare Case Report
Authors
##plugins.themes.bootstrap3.article.main##
Abstract
Background: Phyllodes tumours (PTs) are rare fibroepithelial neoplasms of the breast, constituting less than 1% of all breast tumours. Among these, malignant PTs with heterologous sarcomatous differentiation, particularly liposarcomatous transformation, are exceedingly uncommon and pose significant diagnostic challenges. Case Presentation: We report the case of a 55-year-old woman who presented with a painless, mobile breast lump initially suspected to be a benign lesion. Imaging suggested a lipoma, but fine-needle aspiration cytology revealed atypical cells, prompting surgical excision. Histopathological examination confirmed a malignant phyllodes tumour with liposarcomatous differentiation. Immunohistochemistry showed S100 positivity and was negative for MDM2 and CDK4, supporting the diagnosis and excluding primary breast liposarcoma. The patient subsequently underwent a left mastectomy, with no residual tumour detected and remains under close follow-up without recurrence. Conclusion: This case underscores the importance of integrating clinical, radiological, histopathological, and immunohistochemical findings in diagnosing rare variants of malignant PTs. Recognizing liposarcomatous differentiation within PTs is critical, as it influences prognosis and helps differentiate them from primary breast sarcomas.
##plugins.themes.bootstrap3.article.details##
Copyright (c) 2025 Kirthika Arunachalam, Mohanapriya Thyagarajan, Kishor Rasipurathanur Jaghannathan

This work is licensed under a Creative Commons Attribution 4.0 International License.
Creative Commons License All articles published in Annals of Medicine and Medical Sciences are licensed under a Creative Commons Attribution 4.0 International License.
[1] Dyer N.H., Bridger J.E., Taylor R.S. Cystosarcoma phylloides. Br. J. Surg. 1966;53:450-455. doi: 10.1002/bjs.1800530517.
[2] Parker, Harries S.A. Phyllodes tumours. Postgrad. Med. J. 2001;77:428-435. doi: 10.1136/pmj.77.909.428.
[3] Telli M.L., Horst K.C., Guardino A.E., Dirbas F.M., Carlson R.W. Phyllodes tumors of the breast: natural history, diagnosis, and treatment. J. Nat. Compr. Cancer Netw. 2007;5:324-330. doi: 10.6004/jnccn.2007.0027.
[4] Guerrero M.A., Ballard B.R., Grau A.M. Malignant phyllodes tumor of the breast: review of the literature and case report of stromal overgrowth. Surg. Oncol. 2003;12:27-37. doi: 10.1016/s0960-7404(03)00005-7
[5] Austin RM, Dupree WB. Liposarcoma of the breast: a clinicopathologic study of 20 cases. Hum Pathol, 1986, 17(9):906- 913
[6] Tan B.Y., Acs G., Apple S.K., Badve S., Bleiweiss I.J., Brogi E. Phyllodes tumours of the breast: a consensus review. Histopathology. 2016;68:5-21. doi: 10.1111/his.12876
[7] Inyang A, Thomas DG, Jorns J. Heterologous liposarcomatous differentiation in malignant phyllodes tumor is histologically similar but immunohistochemically and molecularly distinct from well-differentiated liposarcoma of soft tissue. Breast J, 2016, 22(3):282-286.
[8] Lin JJ, Huang CS, Yu J, et al. Malignant phyllodes tumors display mesenchymal stem cell features and aldehyde dehydrogenase/disialoganglioside identify their tumor stem cells. Breast Cancer Res 2014;16:R29
[9] Tu He Ta Mi Shi ME, Wang N, Yao Q, et al. A Case of Phyllodes Tumor of the Breast with Mixed Liposarcoma: Case Report and Literature Review. Onco Targets Ther. 2021;14:3003-3011. Published 2021 May 6. doi:10.2147/OTT.S298379
[10] Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ, editors. World Health Organization (WHO) Classification of tumours of the breast. In: WHO Classification of Tumours. Vol. 4, 4th ed. Lyon, France:International Agency for Research on Cancer (IARC) Press;2012:143-147
[11] Hasdemir S, Tolunay Ş, Özşen M, Gökgöz MŞ. Phyllodes tumor of the breast: a clinicopathological evaluation of 55 cases. Eur j Breast Health. 2020;16(1):32-38. doi: 10.5152/ejbh.2019.4709
[12] Subramanian J, Nair R, Nayal B, Rao L. Malignant phyllodes tumor with osteosarcomatous differentiation - a case report. Med Res Chron. 2014;1(2):193-196.
[13] Atram M, Gupta A, Gangane NM. Malignant Phyllodes Tumor with Heterologous Sarcomatous Differentiation: A Case Series and Review of Literature. Indian J Surg Oncol. 2022;13(4):723-730. doi:10.1007/s13193-022-01525-7
[14] Isotalo PA, George RL, Walker R, Sengupta SK. Malignant phyllodes tumor with liposarcomatous differentiation. Arch Pathol Lab Med. 2005;129:421-422. doi: 10.5858/2005-129-421-MPTWLD.